Treatment of cancer in old age, shortcomings and challenges

Netherlands Journal of Medicine

Volumn 59, Issue 5, 2001, Pages 259-266

  Wymenga, A N M ^a   Slaets, J P J ^a   Sleijfer, D Th ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cancer; Cancer treatment; Frailty

Indexed keywords

AGE; CANCER; CANCER INCIDENCE; CANCER THERAPY; COMORBIDITY; DECISION MAKING; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; HUMAN; LIFE EXPECTANCY; QUALITY OF LIFE; REVIEW; SENESCENCE;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; COMORBIDITY; FRAIL ELDERLY; HUMANS; LIFE EXPECTANCY; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; REFERRAL AND CONSULTATION;

EID: 0034764970     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(01)00160-7     Document Type: Review

References (57)

1. Cancer burden in the aged; an epidemiologic and demographic overview
2. Relative survival in elderly patients in Europe
3. Biology of aging as related to cancer
4. Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, the Netherlands
5. Investigation and treatment of cancer in old age
6. Cancer in old age, is it inadequately investigated and treated?
7. Age:a critical factor in cancer management. A prospective comparative study of 400 patients
8. Delayed diagnosis of gynecologic tumors in elderly women: relation to national medical practice patterns
9. Rectal examinations in elderly subjects: attitudes of patients and doctors
10. Myths and biases related to cancer in the elderly
11. Clinical aspects of cancer in the elderly; Treatment decisions, treatment choices, and follow up
12. National survey of ovarian carcinoma IV; patterns of care and related survival for older patients
13. Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions
14. Postoperative radiotherapy for endometrial carcinoma stage I. Wide variation in referral patterns but no effect on long-term survival in a retrospective study in the Southeast Netherlands
15. Comorbidity in patients with prostate cancer and its relevance in treatment choice
16. The concept of Tenju-gann, or 'Natural-end cancer'
17. Cancer death and older age
18. Underrepresentation of patients 65 years of age or older in cancer-treatment trials
19. Representation of older patients in cancer treatment trials
20. Different age limits for elderly patients with indolent and aggressive Non-Hodgkin lymphoma and the role of relative survival with increasing age
21. Levamisol and fluorouracil for adjuvant therapy of resected colon carcinoma
22. Diseases and disorders of ageing: an hypothesis
23. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study
24. Comorbidity and colorectal cancer according to subsite and stage: a population-based study
25. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients
26. The effect of comorbidity on 3-year survival of women with primary breast cancer
27. Chronische polyfarmacie bij eenderde van de ouderen in de huisartspraktijk
28. Declining physical abilities with age: a cross-sectional study of older twins and centenarians in Denmark
29. Determinants of cancer therapy in elderly patients
30. The impact of cancer on the physical function of the elderly and their utilization of health care
31. The interaction of age, symptoms, and survival status on physical and mental health of patients with cancer and their families
32. Failure of physicians to recognize functional disability in ambulatory patients
33. How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems. Data from a survey of five oncologists
34. Who are the frail elderly?
35. Screening for frailty: Criteria and predictors of outcomes
36. Antecedents of frailty over three decades in an older cohort
37. Comorbidity and functional status are independent in older cancer patients
38. A comprehensive geriatric assessment (CGA) is necessary for the study and the management of cancer in the elderly
39. Geriatric assessment in oncology
40. Validation of a multidimensional evaluation scale for use in elderly cancer patients
41. A brief clinical instrument to classify frailty in elderly people
42. Management of the frail person with advanced cancer
43. Age and clinical decision making in oncology patients
44. Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy
45. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews
46. How older patients'treatment preferences are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancer
47. Assessing quality of life in cancer patients
48. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology
49. The functional assessment of cancer therapy scale: Development and validation of the general measure
50. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist
51. Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: Report of a workshop
52. Assessing quality of life of patients with cancer: East meets West
53. Measuring quality of life in palliative care
54. Palliative medicine in the elderly
55. Cancer in the elderly: Why so badly treated